Baytacare Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended 31 March, 2017. For the quarter, turnover was RMB 6,177,000. Operating loss was RMB 6,707,000 against loss of RMB 937,000 for the same period prior year. Loss before and after taxation was RMB 6,808,000 against loss of RMB 943,000 for the same period prior year. Total comprehensive loss attributable to shareholders was RMB 6,808,000 against loss of RMB 943,000 for the same period prior year. Loss per share-basic was 0.80 cents against loss of 0.10 cents for the same period prior year.